Journal article
Prognostic Value of Baseline Plasma Amino-Terminal Pro-Brain Natriuretic Peptide and Its Interactions With Irbesartan Treatment Effects in Patients With Heart Failure and Preserved Ejection Fraction
Abstract
BACKGROUND: Plasma concentrations of natriuretic peptides (NPs) are associated with morbidity and mortality in patients with systolic heart failure (HF). However, the role of NP as a prognostic marker in patients with HF and preserved ejection fraction (HFpEF) has not been studied in a large cohort of well-characterized patients. Moreover, it is unclear whether treatments have a differential effect on morbidity and mortality across the spectrum …
Authors
Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM
Journal
Circulation Heart Failure, Vol. 4, No. 5, pp. 569–577
Publisher
Wolters Kluwer
Publication Date
9 2011
DOI
10.1161/circheartfailure.111.962654
ISSN
1941-3289
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AgedAged, 80 and overAngiotensin II Type 1 Receptor BlockersBiomarkersBiphenyl CompoundsDouble-Blind MethodFemaleHeart FailureHospitalizationHumansIrbesartanKaplan-Meier EstimateMaleMiddle AgedNatriuretic Peptide, BrainPeptide FragmentsPredictive Value of TestsPrognosisStroke VolumeSurvival RateTetrazolesTreatment Outcome